Clinical and Radiographic Outcomes for Patients with IDH Mutant Gliomas using Ivosidenib
Research Grant
Awarded By
Servier Pharmaceuticals
Start Date
September 9, 2024
End Date
July 31, 2027
Awarded By
Servier Pharmaceuticals
Start Date
September 9, 2024
End Date
July 31, 2027